Methylprednisolone Withdrawn Phase 3 Trials for Graft Versus Host Disease (GVHD) / Malignant Lymphomas / Leukemias Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00006451Bone Marrow Transplantation in Treating Patients With Leukemia